On Thursday 07/11/2024 the closing price of the Colgate-Palmolive Co. share was $98.06 on BTT.
Compared to the opening price on Thursday 07/11/2024 on BTT of $97.99, this is a gain of 0.07%.
Colgate-Palmolive Co.'s market capitalization is $80.50 B by 820.44 M shares outstanding.
Is Colgate-Palmolive stock a Buy, Sell or Hold?
Colgate-Palmolive stock has received a consensus rating of buy. The average rating score is and is based on 39 buy ratings, 23 hold ratings, and 0 sell ratings.What was the 52-week low for Colgate-Palmolive stock?
The low in the last 52 weeks of Colgate-Palmolive stock was 67.63. According to the current price, Colgate-Palmolive is 145.01% away from the 52-week low.What was the 52-week high for Colgate-Palmolive stock?
The high in the last 52 weeks of Colgate-Palmolive stock was 99.08. According to the current price, Colgate-Palmolive is 98.98% away from the 52-week high.What are analysts forecasts for Colgate-Palmolive stock?
The 62 analysts offering price forecasts for Colgate-Palmolive have a median target of 87.63, with a high estimate of 112.00 and a low estimate of 73.00. The median estimate represents a 111.91 difference from the last price of 98.07.Colgate-Palmolive Stock Snapshot
98.12
Bid
100.00
Bid Size
98.38
Ask
100.00
Ask Size
7/12/2024
Date
6:21 PM
Time
121,637.00
Volume
98.06
Prev. Close
97.99
Open
820.44 M
Number of Shares
97.93
Day Low
98.63
Day High
98.07
67.63
52 Week Low
99.08
52 Week High
98.07
1.91
Dividend in USD
2.40
Dividend Yield
28.74
P/E Ratio
99.90
Free Float in %
2.78
EPS in USD
0.74
Book Value per Share in USD
4.52
Cash Flow per Share in USD
Colgate-Palmolive News More News
Historical Prices for Colgate-Palmolive
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
Colgate-Palmolive Analyst Data
Total Analysts: 62
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 73.00
Median: 87.63
Highest: 112.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Colgate-Palmolive Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price | |||
|---|---|---|---|---|---|---|
| 07/10/24 | Citigroup Corp. | Maintained Buy | $112 | |||
| 07/10/24 | Bank of America Merrill Lynch | Maintained Buy | $110 | |||
| 07/10/24 | Wells Fargo & Co | Maintained Hold | $97 | |||
| 06/24/24 | Exane BNP Paribas | Maintained Buy | $109 | |||
| 05/28/24 | Morgan Stanley | Maintained Buy | $103 | |||
| 05/15/24 | Argus Research Company | Maintained Buy | $107 | |||
| 04/30/24 | Barclays Capital | Maintained Hold | $85 | |||
| 04/29/24 | Wells Fargo & Co | Maintained Hold | $92 | |||
| 04/29/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $95 | |||
| 04/29/24 | Bank of America Merrill Lynch | Maintained Buy | $100 | |||
| 04/29/24 | RBC Capital Markets | Maintained Hold | $95 | |||
| 04/16/24 | Citigroup Corp. | Maintained Buy | $100 | |||
| 04/12/24 | Barclays Capital | Maintained Hold | $84 | |||
| 04/10/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $94 | |||
| 04/08/24 | Evercore | Maintained Buy | $96 | |||
| 03/01/24 | Goldman Sachs | Maintained Buy | $93 | |||
| 01/29/24 | Morgan Stanley | Maintained Buy | $93 | |||
| 01/29/24 | UBS | Maintained Buy | $95 | |||
| 01/29/24 | Wells Fargo & Co | Maintained Hold | $88 | |||
| 01/29/24 | Raymond James Financial, Inc. | Upgraded to Buy | $91 | |||
| 01/18/24 | J.P. Morgan | Maintained Buy | $90 | |||
| 01/16/24 | Barclays Capital | Maintained Hold | $82 | |||
| 12/15/23 | Bank of America Merrill Lynch | Upgraded to Buy | $90 | |||
| 11/29/23 | J.P. Morgan | Maintained Buy | $88 | |||
| 11/13/23 | Jefferies & Company Inc. | Maintained Buy | $87 | |||
| 10/30/23 | RBC Capital Markets | Maintained Hold | $80 | |||
| 10/30/23 | Morgan Stanley | Maintained Buy | $85 | |||
| 10/17/23 | Bank of America Merrill Lynch | Maintained Hold | $75 | |||
| 10/16/23 | Stifel, Nicolaus & Co., Inc. | Upgraded to Buy | $81 | |||
| 10/12/23 | Barclays Capital | Maintained Hold | $73 | |||
| 10/12/23 | J.P. Morgan | Maintained Buy | $81 | |||
| 10/11/23 | Citigroup Corp. | Maintained Buy | $85 | |||
| 09/22/23 | HSBC | Maintained Buy | $84 | |||
| 08/01/23 | Barclays Capital | Maintained Hold | $81 | |||
| 07/31/23 | RBC Capital Markets | Maintained Hold | $83 | |||
| 07/31/23 | Deutsche Bank | Maintained Buy | $91 | |||
| 05/01/23 | Bank of America Merrill Lynch | Maintained Hold | $85 | |||
| 05/01/23 | Evercore | Maintained Buy | $91 | |||
| 05/01/23 | RBC Capital Markets | Maintained Hold | $83 | |||
| 05/01/23 | Goldman Sachs | Maintained Buy | $96 | |||
| 05/01/23 | Morgan Stanley | Maintained Buy | $89 | |||
| 05/01/23 | Wells Fargo & Co | Maintained Hold | $81 | |||
| 05/01/23 | Citigroup Corp. | Maintained Buy | $92 | |||
| 03/29/23 | UBS | Maintained Buy | $86 | |||
| 03/20/23 | Deutsche Bank | Maintained Buy | $80 | |||
| 02/17/23 | Citigroup Corp. | Maintained Buy | $84 | |||
| 01/31/23 | Barclays Capital | Maintained Hold | $77 | |||
| 01/30/23 | Wells Fargo & Co | Maintained Hold | $76 | |||
| 01/30/23 | Morgan Stanley | Upgraded to Buy | $82 | |||
| 01/13/23 | J.P. Morgan | Maintained Buy | $86 |
Colgate-Palmolive Estimates* in USD
| 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|
| Revenue | 20,193 | 21,023 | 21,932 | 23,078 | 23,293 |
| Dividend | 2.01 | 2.10 | 2.18 | 2.26 | 2.23 |
| Dividend Yield (in %) | 2.05 % | 2.14 % | 2.22 % | 2.31 % | 2.28 % |
| EPS | 3.52 | 3.84 | 4.19 | 4.56 | 4.81 |
| P/E Ratio | 27.83 | 25.53 | 23.38 | 21.51 | 20.40 |
| EBIT | 4,380 | 4,676 | 5,015 | 5,327 | 5,534 |
| EBITDA | 4,995 | 5,307 | 5,667 | 6,026 | 6,279 |
| Net Profit | 2,898 | 3,130 | 3,375 | 3,497 | 3,766 |
| Net Profit Adjusted | 2,901 | 3,130 | 3,375 | 3,432 | - |
| Pre-Tax Profit | 4,054 | 4,363 | 4,706 | 4,826 | - |
| Net Profit (Adjusted) | 4,041 | 4,395 | 4,773 | 4,826 | - |
| EPS (Non-GAAP) ex. SOE | 3.52 | 3.84 | 4.19 | 4.56 | 4.81 |
| EPS (GAAP) | 3.50 | 3.86 | 4.21 | - | - |
| Gross Income | 12,108 | 12,648 | 13,185 | - | - |
| Cash Flow from Investing | -2,690 | -3,097 | -3,593 | - | - |
| Cash Flow from Operations | 3,844 | 4,116 | 4,406 | - | - |
| Cash Flow from Financing | -2,690 | -3,097 | -3,593 | - | - |
| Cash Flow per Share | 4.54 | 4.89 | 5.17 | 5.63 | 6.00 |
| Free Cash Flow | 3,122 | 3,387 | 3,618 | 3,643 | - |
| Free Cash Flow per Share | 4.08 | 4.60 | 5.01 | - | - |
| Book Value per Share | 0.62 | 1.09 | 1.78 | 4.78 | 6.42 |
| Net Debt | 7,383 | 6,944 | 6,561 | 5,550 | 3,001 |
| Research & Development Exp. | 353 | 358 | 370 | - | - |
| Capital Expenditure | 667 | 704 | 740 | 763 | 699 |
| Selling, General & Admin. Exp. | 6,055 | 6,285 | 5,963 | - | - |
| Shareholder’s Equity | 800 | 1,050 | 1,529 | 3,794 | 5,030 |
| Total Assets | 16,843 | 17,397 | 17,928 | - | - |
|
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | 18 | 18 | 18 | 21 | 21 |
| Average Estimate | 0.867 USD | 0.878 USD | 0.917 USD | 3.524 USD | 3.841 USD |
| Year Ago | 0.605 USD | 0.858 USD | 0.872 USD | 2.780 USD | - |
| Publish Date | 7/26/2024 | 10/25/2024 | 1/24/2025 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | 14 | 14 | 14 | 19 | 20 |
| Average Estimate | 5,015 USD | 5,030 USD | 5,090 USD | 20,193 USD | 21,023 USD |
| Year Ago | 4,822 USD | 4,915 USD | 4,950 USD | 19,457 USD | - |
| Publish Date | 7/26/2024 | 10/25/2024 | 1/24/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales | 19,457.00 | 17,967.00 | 17,421.00 | 16,471.00 | 15,693.00 | 15,544.00 | 15,454.00 |
| Change of sales in % | 8.29 | 3.13 | 5.77 | 4.96 | 0.96 | 0.58 | 1.70 |
| Gross profit on sales | 11,251.00 | 10,150.00 | 10,293.00 | 9,933.00 | 9,277.00 | 9,206.00 | 9,323.00 |
| Gross profit on sales change in % | 10.85 | -1.39 | 3.62 | 7.07 | 0.77 | -1.25 | 2.09 |
| Operating income | 4,131.00 | 3,585.00 | 3,886.00 | 3,911.00 | 3,762.00 | 3,850.00 | 3,915.00 |
| Operating income change in % | 15.23 | -7.75 | -0.64 | 3.96 | -2.29 | -1.66 | -1.14 |
| Income before tax | 3,392.00 | 2,660.00 | 3,087.00 | 3,647.00 | 3,301.00 | 3,464.00 | 3,487.00 |
| Income before tax change in % | 27.52 | -13.83 | -15.36 | 10.48 | -4.71 | -0.66 | -6.71 |
| Income after tax | 2,300.00 | 1,785.00 | 2,166.00 | 2,695.00 | 2,367.00 | 2,400.00 | 2,024.00 |
| Income after tax change in % | 28.85 | -17.59 | -19.63 | 13.86 | -1.38 | 18.58 | -17.08 |
Balance Sheet in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Total liabilities | 15,436.00 | 14,925.00 | 14,069.00 | 14,819.00 | 14,476.00 | 11,964.00 | 12,433.00 |
| Long-term liabilities per share | 13.02 | 13.15 | 11.92 | 12.25 | 12.21 | 9.99 | 10.32 |
| Equity | 957.00 | 806.00 | 971.00 | 1,101.00 | 558.00 | 197.00 | 243.00 |
| Equity change in % | 51.87 | -34.15 | -18.03 | 535.04 | - | -70.00 | 75.31 |
| Balance sheet total | 16,393.00 | 15,731.00 | 15,040.00 | 15,920.00 | 15,034.00 | 12,161.00 | 12,676.00 |
| Balance sheet total change in % | 4.21 | 4.59 | -5.53 | 5.89 | 23.62 | -4.06 | 4.56 |
Key Data in USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales per share | 23.46 | 21.42 | 20.54 | 19.17 | 18.22 | 17.81 | 17.41 |
| P/E ratio (year end quote, basic EPS) | 28.74 | 37.03 | 33.42 | 27.26 | 25.04 | 21.65 | 33.10 |
| P/E ratio (year end quote, diluted EPS) | 28.74 | 37.03 | 33.42 | 27.26 | 25.04 | 21.65 | 33.10 |
| P/E ratio (year end quote) | 28.74 | 37.03 | 33.42 | 27.26 | 25.04 | 21.65 | 33.10 |
| Dividend yield in % | 2.40 | 2.36 | 2.10 | 2.05 | 2.48 | 2.79 | 2.11 |
| Equity ratio in % | 3.72 | 2.55 | 4.05 | 4.67 | 0.78 | -0.84 | -0.47 |
| Debt ratio in % | 94.16 | 94.88 | 93.54 | 93.08 | 96.29 | 98.38 | 98.08 |
Colgate-Palmolive Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| Newman Brian | 06/30/2024 | 196.00 | 2,004.00 | 95.61 | Buy | No |
| Daniels Jennifer | 05/13/2024 | 22,250.00 | 59,698.00 | 94.15 | Sell | No |
| Daniels Jennifer | 05/13/2024 | 22,250.00 | 81,948.00 | 72.29 | Buy | No |
| Edwards Lisa | 05/12/2024 | 1,905.00 | 13,820.00 | n/a | Buy | No |
| HUNDMEJEAN MARTINA | 05/12/2024 | 1,905.00 | 10,525.00 | n/a | Buy | No |
| NORRINGTON LORRIE M | 05/12/2024 | 1,905.00 | 34,274.00 | n/a | Buy | No |
| BILBREY JOHN P | 05/12/2024 | 1,905.00 | 32,198.00 | n/a | Buy | No |
| Newman Brian | 05/12/2024 | 1,587.00 | 1,808.00 | n/a | Buy | No |
| HARRIS C MARTIN | 05/12/2024 | 1,905.00 | 21,204.00 | n/a | Buy | No |
| Nelson Kimberly A | 05/12/2024 | 1,905.00 | 7,209.00 | n/a | Buy | No |
| CAHILL JOHN T | 05/12/2024 | 1,905.00 | 26,890.00 | n/a | Buy | No |
| CAHILLANE STEVEN A | 05/12/2024 | 1,905.00 | 4,719.00 | n/a | Buy | No |
| Tsourapas Panagiotis | 05/08/2024 | 12,000.00 | 5,118.00 | 94.15 | Sell | No |
| Massey Sally | 05/08/2024 | 12,226.00 | 13,924.00 | 94.06 | Sell | No |
| Tsourapas Panagiotis | 05/08/2024 | 12,000.00 | 17,118.00 | 72.29 | Buy | No |
| Massey Sally | 05/08/2024 | 12,226.00 | 26,150.00 | 72.29 | Buy | No |
| Kooyman John W | 05/06/2024 | 3,497.00 | 3,181.00 | 93.48 | Sell | No |
| BILBREY JOHN P | 04/30/2024 | 6,329.00 | 30,236.00 | 91.59 | Sell | No |
| BILBREY JOHN P | 04/30/2024 | 6,329.00 | 36,565.00 | 62.04 | Buy | No |
| Newman Brian | 03/31/2024 | 212.00 | 256.00 | 88.36 | Buy | No |
| BILBREY JOHN P | 03/31/2024 | 240.00 | 30,236.00 | 88.36 | Buy | No |
| Tsourapas Panagiotis | 02/17/2024 | 3,447.00 | 15,041.00 | 83.48 | Sell | No |
| Malcolm Gregory | 02/17/2024 | 262.00 | 8,558.00 | 83.48 | Sell | No |
| Massey Sally | 02/17/2024 | 1,489.00 | 13,924.00 | 83.48 | Sell | No |
| Tsourapas Panagiotis | 02/14/2024 | 4,717.00 | 18,488.00 | 83.57 | Sell | No |
Colgate-Palmolive Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2023 | Colgate-Palmolive Co. | 1.91 | 2.40 | USD |
| 2022 | Colgate-Palmolive Co. | 1.86 | 2.36 | USD |
| 2021 | Colgate-Palmolive Co. | 1.79 | 2.10 | USD |
| 2020 | Colgate-Palmolive Co. | 1.75 | 2.05 | USD |
| 2019 | Colgate-Palmolive Co. | 1.71 | 2.48 | USD |
| 2018 | Colgate-Palmolive Co. | 1.66 | 2.79 | USD |
| 2017 | Colgate-Palmolive Co. | 1.59 | 2.11 | USD |
| 2016 | Colgate-Palmolive Co. | 1.55 | 2.37 | USD |
| 2015 | Colgate-Palmolive Co. | 1.50 | 2.25 | USD |
| 2014 | Colgate-Palmolive Co. | 1.42 | 2.05 | USD |
| 2013 | Colgate-Palmolive Co. | 1.33 | 2.04 | USD |
| 2012 | Colgate-Palmolive Co. | 1.22 | 2.33 | USD |
| 2011 | Colgate-Palmolive Co. | 1.14 | 2.46 | USD |
| 2010 | Colgate-Palmolive Co. | 1.02 | 2.53 | USD |
| 2009 | Colgate-Palmolive Co. | 0.86 | 2.09 | USD |
| 2008 | Colgate-Palmolive Co. | 0.78 | 2.28 | USD |
| 2007 | Colgate-Palmolive Co. | 0.70 | 1.80 | USD |
| 2006 | Colgate-Palmolive Co. | 0.63 | 1.92 | USD |
| 2005 | Colgate-Palmolive Co. | 0.56 | 2.02 | USD |
| 2004 | Colgate-Palmolive Co. | 0.48 | 1.88 | USD |
| 2003 | Colgate-Palmolive Co. | 0.45 | 1.80 | USD |
| 2002 | Colgate-Palmolive Co. | 0.36 | 1.37 | USD |
| 2001 | Colgate-Palmolive Co. | 0.34 | 1.18 | USD |
| 2000 | Colgate-Palmolive Co. | 0.32 | 0.98 | USD |
| 1999 | Colgate-Palmolive Co. | 0.30 | 0.91 | USD |
*Yield of the Respective Date
Colgate-Palmolive Co. Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Press Conference | - | 07/26/2024 | |
| Earnings Report | 0.867 USD | Q2 2024 Earnings Release | 07/26/2024 |
| Earnings Report | 0.878 USD | Q3 2024 Earnings Release | 10/25/2024 |
| Earnings Report | 0.917 USD | Q4 2024 Earnings Release | 01/24/2025 |
| Earnings Report | 0.921 USD | Q1 2025 Earnings Release | 04/25/2025 |
| Earnings Report | 0.945 USD | Q2 2025 Earnings Release | 07/25/2025 |
Colgate-Palmolive Co. Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Annual General Meeting | - | Annual General Meeting | 05/10/2024 |
Colgate-Palmolive Profile
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Moody’s Daily Credit Risk Score
Colgate-Palmolive Shareholder
| Owner | in % |
|---|---|
| Freefloat | 99.90 |
| The Vanguard Group, Inc. | 9.74 |
| Vanguard Group, Inc. (Subfiler) | 9.26 |
| SSgA Funds Management, Inc. | 5.81 |
| State Street Corp. | 5.62 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 4.87 |
| Wellington Management Co. LLP (Wellington Breakout) | 3.23 |
| Vanguard Total Stock Market ETF | 3.16 |
| Vanguard 500 Index Fund | 2.58 |
| BlackRock Fund Advisors | 2.50 |
| Geode Capital Management LLC | 2.33 |
| BlackRock Institutional Trust Co. NA | 2.23 |
| Vanguard Dividend Growth Fund | 2.20 |
| Third Point LLC | 1.35 |
| First Eagle Investment Management LLC | 1.29 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Colgate-Palmolive Management
| Name | Job |
|---|---|
| Noel R. Wallace | Chairman, President & Chief Executive Officer |
| Kim Faulkner | Chief Ethics & Compliance Officer |
| Stanley J. Sutula | Chief Financial Officer |
| Sally Massey | Chief Human Resources Officer |
| David Foster | Chief Information Officer |
| Al Lee | Chief Internal Governance Officer |
| John Faucher | Chief Investor Relations Officer & Executive VP |
| Ann Tracy | Chief Sustainability Officer |
| Stephan Habif | Chief Technology Officer |
| John W. Kooyman | Chief of Staff |
| Betsy Floman Fishbone | EVP, Senior Associates-GC, HR Lit Comp & NA Ops |
| Clifford E. Wilkins | EVP, Senior Association-GC, Technology & Reg |
| Martin J. Collins | EVP-Global Total Rewards & HR Operations |
| Nadine P. Flynn | Executive VP, Senior Associates-GC & Marketing |
| Gregory Malcolm | Executive Vice President & Controller |
| Scott Cain | Executive Vice President-Global Taxation |
| Brigitte H. King | Global Chief Digital Officer |
| Panagiotis Tsourapas | Group President-Europe & Developing Markets |
| Prabha Parameswaran | Group President-Growth & Strategy |
| C. Martin Harris | Independent Director |
| Lisa M. Edwards | Independent Director |
| John T. Cahill | Independent Director |
| Brian O. Newman | Independent Director |
| Kimberly A. Nelson | Independent Director |
| Martina T. Hund-Mejean | Independent Director |
| Steven A. Cahillane | Independent Director |
| John P. Bilbrey | Independent Director |
| Lorrie M. Norrington | Lead Independent Director |
| Ram Raghavan | President-Enterprise Oral Care |
| Gillian Barclay | SVP-Global Public Health & Scientific Affairs |
| Jennifer M. Daniels | Secretary & Chief Legal Officer |
| Eutychus Karuru | Senior Vice President-Audit |
| Phillip G. Shotts | Senior Vice President-Finance |
| Javier Llinas | Senior Vice President-Infrastructure & Operations |
| Lia Arvanitidou | Senior Vice President-Skin Health, PC, HC, R&D |
| Gina Grant | Treasurer & Senior Vice President |
| Derek Gordon | VP & Chief Diversity, Equity & Inclusion Officer |
| Alain Semeneri | VP & GM-Hill's Pet Nutrition-Europe, Middle East |
| Wojciech Krol | VP & General Manager-Central Europe East |
| Taylor Gordy | VP & General Manager-Colgate Northern Europe |
| Eugene Kelly | VP-Global Diversity, Equity & Inclusion |
| Riccardo Ricci | Vice President & General Manager-Brazil |
| Bill van de Graaf | Vice President-Colgate North America |
| Brent Peterson | Vice President-Global Human Resources |
| Paul Kevin McGarry | Vice President-Global Information Technology |
| Scott Campbell | Vice President-Global Marketing |
| Raj Kohli | Vice President-Global Research & Development |
| Angel Dario Belalcazar | Vice President-Global Research & Development |
| Josue M. Muñoz | Vice President-Global Supply Chain |
| Linda Topping | Vice President-Global Supply Chain |
| Philip Durocher | Vice President-North America |